Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Science From Our Sisters

Staff  |  April 1, 2008

Recommended reading from A&R and AC&R

Reading Rheum

Gail C. Davis, RN, EdD; Michael M. Ward, MD  |  April 1, 2008

Handpicked Reviews of Contemporary Literature

Coding Corner Question: April 2008

Staff  |  April 1, 2008

April’s Coding Challenge

Coding Corner Answer: March 2008

Staff  |  April 1, 2008

April’s Coding Answer

Polymyalgia Rheumatica

Staff  |  April 1, 2008

Polymyalgia rheumatica (PMR) is a relatively common cause of widespread aching and stiffness in older adults. PMR can overlap with another rheumatic disease called giant cell arteritis, and symptoms of the two conditions can occur at the same time or separately. (See p. 12 of the March 2008 issue for more on giant cell arteritis.) The typical symptoms of PMR include aching and stiffness around the upper arms, neck, lower back, buttocks, and thighs. Symptoms tend to develop quickly over a period of several days or weeks, and occasionally even overnight.

Audioconference Offers Advice on Pain Associated with Juvenile Arthritis

Staff  |  April 1, 2008

What is the pain puzzle? “It is a bio-psycho social model of pain that is accepted in the field of rheumatology,” according to Michael Rapoff, PhD, professor of pediatrics at the University of Kansas Medical Center in Kansas City and the highlighted speaker for the ARHP audioconference on April 17.

Avoid Compliance Risks When Using Billing Companies

Antanya Chung, CPC, CCP  |  April 1, 2008

Outsourcing your billing to a third party will not alleviate your compliance duties or reduce your risk of a government investigation. Conversely, a relationship with a third-party biller can increase your compliance obligations and raise audit risks.

A New Twist in the Consumerization of Healthcare

Staff  |  April 1, 2008

Who are the new medical consumers? These people behave like medical “shoppers” because they are more mobile than previous generations and are empowered by the Internet. They can research and form opinions about diseases, treatment options, and the best route to recovery—all before stepping foot in to an exam room. This emerging population has been taught that in order to be a health-wise consumer and to get the most value, a patient must take an active role in his or her care.

Strength from Weakness

David S. Pisetsky, MD, PhD  |  April 1, 2008

Perhaps physicians should look at the doors disability opens, too

The Line Between Boost and Ban

Bruce N. Cronstein, MD  |  April 1, 2008

What makes a performance-enhancing drug taboo?

  • « Previous Page
  • 1
  • …
  • 781
  • 782
  • 783
  • 784
  • 785
  • …
  • 814
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences